Green Growth Brands Inc.
A6 · CIK 0001739376 · Biotech
Optical sensor-based yield monitors with real-time mapping software that retrofit onto existing combine harvesters
greengrowth.tech →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $17M
- 5 Form D · Feb 2020
- 80 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $19,790 | |
| Private capital raised | Form D · SEC | $11,394,000 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $1,100,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1789 | Neurogastrx, Inc. | — | $80M |
| 1790 | Azafaros | — | — |
| 1791 | Faknostics, LLC | — | — |
| 1792 | Green Growth Brands Inc. | — | $17M |
| 1793 | PMed Holdings, LLC | — | $1.6M |
| 1794 | Mekanistic Therapeutics, LLC | — | — |
| 1795 | SCIBAC INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- David BhumgaraExecutive Officer
- Dr. Shafik DharamshiDirector
- Gary GalitskyDirector · Executive Officer
- Dr. Gunter HintzDirector
- Peter HorvathDirector · Executive Officer
- Kent KiffnerExecutive Officer
- Edward KistnerExecutive Officer
- Marc LehmannDirector
- Brian LoganExecutive Officer
- David LubottaDirector
- Tim MooreDirector · Executive Officer
- Timothy MooreDirector
- Carli PosnerDirector
- Jean SchottensteinDirector
- Peter SchwartzDirector
- Stephen StotueDirector
- Stephen StouteDirector
- Raymond Whitaker, IIIExecutive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.